[Treatment of haemophilia in Austria]

Wien Klin Wochenschr. 2015 Nov:127 Suppl 3:S115-30. doi: 10.1007/s00508-015-0872-x. Epub 2015 Nov 2.
[Article in German]

Abstract

This guideline which is endorsed by the Austrian Society of Haemophilia, the Austrian Society of Paediatrics, and the Austrian Society of Haematology & Medical Oncology is intended to give a clear and practical guidance for diagnosing and treating haemophilia in Austria. In the treatment of haemophilia there are few controlled interventional trials, and recommendations usually have a rather low level of evidence.The main basis for this paper are the new international guidelines by the World Federation of Hemophilia, published in 2013. These were adapted according to the local situation and experience.Covered topics are diagnostics, control visits, pharmacological treatment options, prophylaxis and treatment in children and adults, possible problems arising in haemophilia carriers and special aspects like home therapy, options for venous catheters, management of various traumas, bleedings and interventions, including dental procedures, and last not least inhibitors and their treatment.

Keywords: Clotting factor concentrates; Desmopressin; Guidelines; Haemophilia.

Publication types

  • English Abstract
  • Practice Guideline

MeSH terms

  • Austria
  • Drug Monitoring / standards
  • Evidence-Based Medicine
  • Hematology / standards*
  • Hemophilia A / blood
  • Hemophilia A / complications
  • Hemophilia A / diagnosis
  • Hemophilia A / therapy*
  • Hemostatics / administration & dosage*
  • Hemostatics / adverse effects
  • Humans
  • Practice Guidelines as Topic*
  • Thromboembolism / chemically induced
  • Thromboembolism / prevention & control*
  • Wounds and Injuries / complications
  • Wounds and Injuries / diagnosis
  • Wounds and Injuries / therapy*

Substances

  • Hemostatics